Incontinentia pigmenti and Behçet's disease: a case of impaired neutrophil chemotaxis. 1996

M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
Department of Dermatology, Tokyo Medical and Dental University, Japan.

We describe a patient with incontinentia pigmenti who developed the clinical picture of intestinal Behçet's disease. Diagnosis of Behçet's disease was base on a recurrent genital and oral ulcer and a positive HLA-B51. Impaired neutrophil chemotactic activity and an elevated plasma IL-6 level were found. Chromosomal study revealed no abnormality in the patient or her family. We discuss the possibility that there are common immunological abnormalities in the two syndromes.

UI MeSH Term Description Entries
D007184 Incontinentia Pigmenti A genodermatosis occurring mostly in females and characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eyes, teeth, central nervous system, and skin appendages. Bloch-Sulzberger Syndrome,Bloch-Siemens Syndrome,Bloch-Siemens-Sulzberger Syndrome,Bloch Sulzberger Syndrome,Syndrome, Bloch-Sulzberger
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001528 Behcet Syndrome Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well. Behcet Disease,Behcet's Disease,Behcet's Syndrome,Triple-Symptom Complex,Adamantiades-Behcet Disease,Behcet Triple Symptom Complex,Behçet Disease,Old Silk Route Disease,Triple Symptom Complex,Adamantiades Behcet Disease,Adamantiades-Behcet Diseases,Behçet Diseases,Symptom Complex, Triple,Triple Symptom Complices
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
December 1975, Archives of dermatology,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
May 2010, Journal of the Chinese Medical Association : JCMA,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
January 1986, Acta dermato-venereologica,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
January 1966, Dermatologica,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
April 2003, Ethiopian medical journal,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
March 1967, Pediatria polska,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
December 1956, Archives belges de dermatologie et de syphiligraphie,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
January 1968, Pediatrie,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
February 1973, The Journal of the Kansas Medical Society,
M Endoh, and H Yokozeki, and R Maruyama, and T Matsunaga, and I Katayama, and K Nishioka
October 2007, Journal francais d'ophtalmologie,
Copied contents to your clipboard!